New guidance on musculoskeletal ultrasound use in psoriatic arthritis was presented at the ACR 2024 meeting, highlighting advances in technology since 2012. The guidance emphasizes the role of MSUS in diagnosis, monitoring, and predicting disease progression, with a focus on shared decision-making between patients and healthcare providers. Clinicians should consider patient characteristics when interpreting ultrasound findings and use MSUS as a tool to guide therapy escalation or de-escalation. The guidance also addresses the importance of patient education and communication about disease activity using ultrasound findings. As the field continues to evolve, MSUS is increasingly becoming part of the standard of care.
Source link
New Guidance Updates Ultrasound Use for Psoriatic Arthritis
